Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes

被引：6

作者：

Ai, Jianzhong ^{[1
]}

He, Yong ^{[2
]}

Zheng, Mingxia ^{[2
]}

Wen, Yi ^{[2
]}

Zhang, Huan ^{[2
]}

Huang, Fangyang ^{[2
]}

Zhu, Ye ^{[2
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Urol, Inst Urol, Chengdu, Sichuan, Peoples R China

[2] Sichuan Univ, West China Hosp, Dept Cardiol, Guoxue Xiang 37, Chengdu 610041, Sichuan, Peoples R China

来源：

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | 2018年 / 48卷 / 05期

基金：

中国国家自然科学基金; 国家重点研发计划;

关键词：

Adeno-associated virus; Safety profile; Gene therapy; Heart diseases; Transduction efficacy; GENE-THERAPY; RENEWAL;

D O I：

10.1159/000492510

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Background/Aims: Cardiovascular diseases (CVD) are the leading causes for human mortality. However, the effective treatment for these diseases are still lacking. Currently, gene therapy could be a potential way for efficiently treating heart diseases. The aim of our study is to analyze the transduction efficacy and safety profile of recombinant adeno associated virus (AAV) serotype 9 for cardiomyocytes in vivo and in vitro. Methods: We produced rAAV serotype 9 expressing enhanced green fluorescence protein (EGFP) driven by a cardiac troponin T (cTNT) promoter, and characterized its transduction efficiency in primary cultured cardiomyocytes in vitro, and in wild-type mouse heart tissue in vivo. Results: Our data showed that rAAV9 efficiently transduced mouse cardiomyocytes in vitro. Following intravenous injection, rAAV9 could efficiently and safely transduce cardiomyocytes that are involved in heart diseases. Conclusion: Our findings suggested that rAAV9 can efficiently and safely transduce cardiomyocytes in vitro and/or in vivo. The rAAV9 serotype vector could constitute a powerful toolbox for future gene therapy of heart diseases. (C) 2018 The Author(s) Published by S. Karger AG, Basel

引用

页码：1894 / 1900

页数：7

共 17 条

[11]

Gao G., 2012, INTRO GENES MAMMALIA

[12] Innate immunity and cardiomyocytes in ischemic heart disease [J].

Lin, Li ;

Knowlton, Anne A. .

LIFE SCIENCES, 2014, 100 (01) :1-8

[13] Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B [J].

Nathwani, Amit C. ;

Tuddenham, Edward G. D. ;

Rangarajan, Savita ;

Rosales, Cecilia ;

McIntosh, Jenny ;

Linch, David C. ;

Chowdary, Pratima ;

Riddell, Anne ;

Pie, Arnulfo Jaquilmac ;

Harrington, Chris ;

O'Beirne, James ;

Smith, Keith ;

Pasi, John ;

Glader, Bertil ;

Rustagi, Pradip ;

Ng, Catherine Y. C. ;

Kay, Mark A. ;

Zhou, Junfang ;

Spence, Yunyu ;

Morton, Christopher L. ;

Allay, James ;

Coleman, John ;

Sleep, Susan ;

Cunningham, John M. ;

Srivastava, Deokumar ;

Basner-Tschakarjan, Etiena ;

Mingozzi, Federico ;

High, Katherine A. ;

Gray, John T. ;

Reiss, Ulrike M. ;

Nienhuis, Arthur W. ;

Davidoff, Andrew M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (25) :2357-2365

[14] Mammalian heart renewal by pre-existing cardiomyocytes [J].

Senyo, Samuel E. ;

Steinhauser, Matthew L. ;

Pizzimenti, Christie L. ;

Yang, Vicky K. ;

Cai, Lei ;

Wang, Mei ;

Wu, Ting-Di ;

Guerquin-Kern, Jean-Luc ;

Lechene, Claude P. ;

Lee, Richard T. .

NATURE, 2013, 493 (7432) :433-U186

[15] Recombinant Adeno-Associated Virus Serotype 6 Efficiently Transduces Primary Human Melanocytes [J].

Sheppard, Hilary M. ;

Ussher, James E. ;

Verdon, Daniel ;

Chen, Jennifer ;

Taylor, John A. ;

Dunbar, P. Rod .

PLOS ONE, 2013, 8 (04)

[16] Adeno-associated virus (AAV) gene therapy for neurological disease [J].

Weinberg, Marc S. ;

Samulski, R. Jude ;

McCown, Thomas J. .

NEUROPHARMACOLOGY, 2013, 69 :82-88

[17] Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure Analysis of Recurrent Cardiovascular Events and Mortality [J].

Zsebo, Krisztina ;

Yaroshinsky, Alex ;

Rudy, Jeffrey J. ;

Wagner, Kim ;

Greenberg, Barry ;

Jessup, Mariell ;

Hajjar, Roger J. .

CIRCULATION RESEARCH, 2014, 114 (01) :101-108

← 1 2 →